Want to see SXTP full AI Analyst Report?
60 Degrees Pharmaceuticals, Inc. (SXTP) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tafenoquine 100Mg | Chronic Babesiosis | Phase II | Not Yet Recruiting | B-FREE Chronic Babesiosis Study | Oct 22, 2024 | ― |
| Tafenoquine Oral Tablet | Covid 19 Disease | Phase II | Completed | Tafenoquine in Patients With Mild to Moderate COVID-19 | Aug 28, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tafenoquine 100Mg | Phase II | Chronic Babesiosis | Not Yet Recruiting | B-FREE Chronic Babesiosis Study | Oct 22, 2024 | ― |
| Tafenoquine Oral Tablet | Phase II | Covid 19 Disease | Completed | Tafenoquine in Patients With Mild to Moderate COVID-19 | Aug 28, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does 60 Degrees Pharmaceuticals, Inc. (SXTP) have in its pipeline
60 Degrees Pharmaceuticals, Inc. SXTP is currently developing the following drugs: Tafenoquine 100Mg, Tafenoquine Oral Tablet. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
